For people with inflammatory arthritis, overall COVID-19 risks are low and similar to those in the general population. INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people […]
Category: Population characteristics
Economic status, location, and healthcare system impact how well treatments work in trials
More consistent reporting of patient characteristics is needed across rheumatology trials. INTRODUCTION Rheumatic diseases affect people’s joints, bones, tendons, ligaments and muscles – and often also other organs. Many of these diseases are autoimmune conditions that cause inflammation in the body. There are more than 200 rheumatic diseases, including rheumatoid arthritis, osteoarthritis, psoriatic arthritis, spondyloarthritis, […]